Cargando…

The Precautionary Principle, Evidence-Based Medicine, and Decision Theory in Public Health Evaluation

The precautionary principle (PP) has been used in the evaluation of the effectiveness and/or cost-effectiveness of interventions designed to prevent future harms in a range of activities, particularly in the area of the environment. Here, we provide details of circumstances under which the PP can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Alastair J., Ghelardi, Gemma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935673/
https://www.ncbi.nlm.nih.gov/pubmed/27458575
http://dx.doi.org/10.3389/fpubh.2016.00107
_version_ 1782441434380500992
author Fischer, Alastair J.
Ghelardi, Gemma
author_facet Fischer, Alastair J.
Ghelardi, Gemma
author_sort Fischer, Alastair J.
collection PubMed
description The precautionary principle (PP) has been used in the evaluation of the effectiveness and/or cost-effectiveness of interventions designed to prevent future harms in a range of activities, particularly in the area of the environment. Here, we provide details of circumstances under which the PP can be applied to the topic of harm reduction in Public Health. The definition of PP that we use says that the PP reverses the onus of proof of effectiveness between an intervention and its comparator when the intervention has been designed to reduce harm. We first describe the two frameworks used for health-care evaluation: evidence-based medicine (EBM) and decision theory (DT). EBM is usually used in treatment effectiveness evaluation, while either EBM or DT may be used in evaluating the effectiveness of the prevention of illness. For cost-effectiveness, DT is always used. The expectation in Public Health is that interventions employed to reduce harm will not actually increase harm, where “harm” in this context does not include opportunity cost. That implies that an intervention’s effectiveness can often be assumed. Attention should therefore focus on its cost-effectiveness. This view is consistent with the conclusions of DT. It is also very close to the PP notion of reversing the onus of proof, but is not consistent with EBM as normally practiced, where the onus is on showing a new practice to be superior to usual practice with a sufficiently high degree of certainty. Under our definitions, we show that where DT and the PP differ in their evaluation is in cost-effectiveness, but only for decisions that involve potential catastrophic circumstances, where the nation-state will act as if it is risk-averse. In those cases, it is likely that the state will pay more, and possibly much more, than DT would allow, in an attempt to mitigate impending disaster. That is, the rules that until now have governed all cost-effectiveness analyses are shown not to apply to catastrophic situations, where the PP applies.
format Online
Article
Text
id pubmed-4935673
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-49356732016-07-25 The Precautionary Principle, Evidence-Based Medicine, and Decision Theory in Public Health Evaluation Fischer, Alastair J. Ghelardi, Gemma Front Public Health Public Health The precautionary principle (PP) has been used in the evaluation of the effectiveness and/or cost-effectiveness of interventions designed to prevent future harms in a range of activities, particularly in the area of the environment. Here, we provide details of circumstances under which the PP can be applied to the topic of harm reduction in Public Health. The definition of PP that we use says that the PP reverses the onus of proof of effectiveness between an intervention and its comparator when the intervention has been designed to reduce harm. We first describe the two frameworks used for health-care evaluation: evidence-based medicine (EBM) and decision theory (DT). EBM is usually used in treatment effectiveness evaluation, while either EBM or DT may be used in evaluating the effectiveness of the prevention of illness. For cost-effectiveness, DT is always used. The expectation in Public Health is that interventions employed to reduce harm will not actually increase harm, where “harm” in this context does not include opportunity cost. That implies that an intervention’s effectiveness can often be assumed. Attention should therefore focus on its cost-effectiveness. This view is consistent with the conclusions of DT. It is also very close to the PP notion of reversing the onus of proof, but is not consistent with EBM as normally practiced, where the onus is on showing a new practice to be superior to usual practice with a sufficiently high degree of certainty. Under our definitions, we show that where DT and the PP differ in their evaluation is in cost-effectiveness, but only for decisions that involve potential catastrophic circumstances, where the nation-state will act as if it is risk-averse. In those cases, it is likely that the state will pay more, and possibly much more, than DT would allow, in an attempt to mitigate impending disaster. That is, the rules that until now have governed all cost-effectiveness analyses are shown not to apply to catastrophic situations, where the PP applies. Frontiers Media S.A. 2016-07-07 /pmc/articles/PMC4935673/ /pubmed/27458575 http://dx.doi.org/10.3389/fpubh.2016.00107 Text en Copyright © 2016 Fischer and Ghelardi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Fischer, Alastair J.
Ghelardi, Gemma
The Precautionary Principle, Evidence-Based Medicine, and Decision Theory in Public Health Evaluation
title The Precautionary Principle, Evidence-Based Medicine, and Decision Theory in Public Health Evaluation
title_full The Precautionary Principle, Evidence-Based Medicine, and Decision Theory in Public Health Evaluation
title_fullStr The Precautionary Principle, Evidence-Based Medicine, and Decision Theory in Public Health Evaluation
title_full_unstemmed The Precautionary Principle, Evidence-Based Medicine, and Decision Theory in Public Health Evaluation
title_short The Precautionary Principle, Evidence-Based Medicine, and Decision Theory in Public Health Evaluation
title_sort precautionary principle, evidence-based medicine, and decision theory in public health evaluation
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935673/
https://www.ncbi.nlm.nih.gov/pubmed/27458575
http://dx.doi.org/10.3389/fpubh.2016.00107
work_keys_str_mv AT fischeralastairj theprecautionaryprincipleevidencebasedmedicineanddecisiontheoryinpublichealthevaluation
AT ghelardigemma theprecautionaryprincipleevidencebasedmedicineanddecisiontheoryinpublichealthevaluation
AT fischeralastairj precautionaryprincipleevidencebasedmedicineanddecisiontheoryinpublichealthevaluation
AT ghelardigemma precautionaryprincipleevidencebasedmedicineanddecisiontheoryinpublichealthevaluation